Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2019 07:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics to Present New Data at the American Association for Cancer Research (AACR) Annual Meeting 2019

NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
January 03, 2019 14:30 ET | Source: Incysus Therapeutics, Inc.

Gamma-Delta T Cell Immunotherapy Pioneer, Lawrence Lamb, PhD, to Join Incysus Therapeutics as Chief Scientific Officer

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
January 03, 2019 14:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics Completes Series A Financing and Announces the Appointment of Travis Whitfill, MPH to Its Board of Directors

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
November 28, 2018 16:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics Announces Presentations at 2018 ASH and HAPLO Annual Meetings

NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
November 15, 2018 07:00 ET | Source: Incysus Therapeutics, Inc.

Gamma-Delta (γδ) T Cell Therapy Combined With Checkpoint Inhibition Shows Potential Synergies in Vitro for Treatment of Glioblastoma

Promising data from gamma-delta (γδ) T cell therapy in combination with checkpoint inhibitors to be presented at 2018 Society for Neuro-Oncology annual meeting NEW YORK, Nov. 15, 2018 (GLOBE...
October 22, 2018 08:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics to Participate in Panel at the 2018 Life Sciences Summit

Panel Title: “Therapeutic Insight: Immuno-Oncology’s Next Generation Therapies” NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company...